NO20032198L - 1-metylkarbapenemderivater - Google Patents

1-metylkarbapenemderivater

Info

Publication number
NO20032198L
NO20032198L NO20032198A NO20032198A NO20032198L NO 20032198 L NO20032198 L NO 20032198L NO 20032198 A NO20032198 A NO 20032198A NO 20032198 A NO20032198 A NO 20032198A NO 20032198 L NO20032198 L NO 20032198L
Authority
NO
Norway
Prior art keywords
hydrogen atom
group
alkyl group
formula
represented
Prior art date
Application number
NO20032198A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032198D0 (no
Inventor
Tsuyoshi Shinozuka
Osamu Kanno
Yoshiyuki Kobayashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20032198D0 publication Critical patent/NO20032198D0/no
Publication of NO20032198L publication Critical patent/NO20032198L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20032198A 2000-11-16 2003-05-15 1-metylkarbapenemderivater NO20032198L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000350063 2000-11-16
PCT/JP2001/009960 WO2002040483A1 (fr) 2000-11-16 2001-11-14 Dérivés 1-méthylcarbapenem

Publications (2)

Publication Number Publication Date
NO20032198D0 NO20032198D0 (no) 2003-05-15
NO20032198L true NO20032198L (no) 2003-07-16

Family

ID=18823361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032198A NO20032198L (no) 2000-11-16 2003-05-15 1-metylkarbapenemderivater

Country Status (24)

Country Link
US (1) US7001897B2 (de)
EP (1) EP1340757B1 (de)
KR (1) KR100832287B1 (de)
CN (1) CN1289498C (de)
AT (1) ATE342266T1 (de)
AU (2) AU1521202A (de)
BR (1) BR0115454A (de)
CA (1) CA2429346A1 (de)
CZ (1) CZ300137B6 (de)
DE (1) DE60123827T2 (de)
DK (1) DK1340757T3 (de)
ES (1) ES2273902T3 (de)
HU (1) HUP0303204A3 (de)
IL (1) IL155931A0 (de)
MX (1) MXPA03004372A (de)
NO (1) NO20032198L (de)
NZ (1) NZ525934A (de)
PL (1) PL362132A1 (de)
PT (1) PT1340757E (de)
RU (1) RU2247725C2 (de)
SK (1) SK5982003A3 (de)
TW (1) TWI242013B (de)
WO (1) WO2002040483A1 (de)
ZA (1) ZA200303796B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1408027A4 (de) * 2001-07-18 2006-08-30 Mitsui Chemicals Inc Diaminderivate, verfahren zur herstellung der diaminderivate und diaminderivate als wirkstoff enthaltende fungizide
KR100451670B1 (ko) * 2001-09-14 2004-10-08 한국화학연구원 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
EP1637529A1 (de) * 2004-09-20 2006-03-22 4Sc Ag Neue Piperidin-4-yl-Thiazol-Carboxamid-Analog als Inhibitoren für die Vermehrung von T-Zellen und ihre Verwendung
US7601745B2 (en) * 2004-09-27 2009-10-13 4Sc Ag Heterocyclic NF-kB inhibitors
EP2009005A4 (de) 2006-04-19 2010-06-02 Astellas Pharma Inc Azolcarbonsäureamidderivat
CN101328179B (zh) * 2007-06-15 2011-01-12 山东轩竹医药科技有限公司 含有氧代氮杂环的巯基吡咯烷培南衍生物
EP2206707B1 (de) 2007-10-24 2014-07-23 Astellas Pharma Inc. Azolecarboxamidverbindung oder salz daraus
ES2533826T3 (es) 2008-01-18 2015-04-15 Merck Sharp & Dohme Corp. Inhibidores de beta-lactamasa
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
JP6363616B2 (ja) 2012-12-19 2018-07-25 ノバルティス アーゲー オートタキシン阻害剤
AR126215A1 (es) * 2021-06-23 2023-09-27 Hoffmann La Roche Proceso novedoso

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272455B1 (de) * 1986-11-24 1993-02-10 Fujisawa Pharmaceutical Co., Ltd. 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]hept-2-en-2-carbonsäure-Derivate
GB9210096D0 (en) * 1992-05-11 1992-06-24 Fujisawa Pharmaceutical Co 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives and their preparation
AU682510B2 (en) * 1993-07-01 1997-10-09 Pfizer Japan Inc. 2-(1-(1,3-thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives
DE4423612A1 (de) * 1994-07-06 1996-01-11 Basf Ag 2-[(Dihydro)pyrazolyl-3'-oxymethylen]-anilide, Verfahren zu ihrer Herstelung und ihre Verwendung
TW445265B (en) * 1996-11-25 2001-07-11 Meiji Seika Kaisha Carbapenem derivatives and antimicrobial agents
TW200403244A (en) * 2002-05-14 2004-03-01 Sankyo Co 1β-Methylcarbapenem derivatives for oral use
JP2004043438A (ja) * 2002-05-15 2004-02-12 Sankyo Co Ltd 1−メチルカルバペネム誘導体を含有する医薬

Also Published As

Publication number Publication date
US20040014962A1 (en) 2004-01-22
DE60123827D1 (en) 2006-11-23
SK5982003A3 (en) 2004-05-04
DK1340757T3 (da) 2007-02-12
HUP0303204A3 (en) 2010-04-28
EP1340757B1 (de) 2006-10-11
NZ525934A (en) 2004-09-24
PT1340757E (pt) 2006-12-29
AU1521202A (en) 2002-05-27
CZ300137B6 (cs) 2009-02-18
RU2247725C2 (ru) 2005-03-10
KR100832287B1 (ko) 2008-05-26
DE60123827T2 (de) 2007-05-31
CA2429346A1 (en) 2002-05-23
AU2002215212B2 (en) 2004-10-14
EP1340757A4 (de) 2005-01-26
CZ20031325A3 (cs) 2003-10-15
NO20032198D0 (no) 2003-05-15
HUP0303204A2 (hu) 2003-12-29
IL155931A0 (en) 2003-12-23
TWI242013B (en) 2005-10-21
CN1289498C (zh) 2006-12-13
PL362132A1 (en) 2004-10-18
ZA200303796B (en) 2004-08-16
ATE342266T1 (de) 2006-11-15
EP1340757A1 (de) 2003-09-03
MXPA03004372A (es) 2003-08-19
US7001897B2 (en) 2006-02-21
KR20030048151A (ko) 2003-06-18
CN1486317A (zh) 2004-03-31
WO2002040483A1 (fr) 2002-05-23
ES2273902T3 (es) 2007-05-16
BR0115454A (pt) 2003-09-23

Similar Documents

Publication Publication Date Title
DE69925141D1 (de) Chinazolin derivate
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
DE60123827D1 (en) 1-methylcarbapenemderivate
ATE145906T1 (de) Benzamid-derivate
IL148875A0 (en) Sulfonyl hydrazide derivatives, their preparation and pharmaceutical compositions containing them
HK1061674A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
DK1209166T3 (da) Hidtil ukendte A-500 359-derivater
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
WO2000078793A3 (en) Antimicrobial agents
ATE243219T1 (de) 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
YU45994A (sh) Farmaceutski preparati za prevenciju i/ili tretiranje gastrointenstinalnih oboljenja uključujući ulkus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application